Literature DB >> 15004153

A late, prolonged activation of the phosphatidylinositol 3-kinase pathway is required for T cell proliferation.

Ferdinand V Lali1, James Crawley, Derek A McCulloch, Brian M J Foxwell.   

Abstract

Activation of the phosphatidylinositol-3 kinase (PI 3-K) pathway is associated with the proliferation of many cell types, including T lymphocytes. However, recent studies in cell lines stably expressing deletion mutants of IL-2R that fail to activate PI 3-K have questioned the requirement for this pathway in cell cycle regulation. In this study with IL-2 and IL-7, we show in primary T cells that, unlike IL-2, IL-7 fails to induce the early activation of PI 3-K seen within minutes and normally associated with cytokine signaling. However, kinetic experiments showed that both of these T cell growth factors induce a distinct and sustained phase of PI 3-K activity several hours after stimulation. This delayed activation correlates with cell cycle induction and from studies using inhibitors of PI 3-K signaling, we show that this later phase, unlike the early activation within minutes, is required for cell cycle induction. The data presented here will have major implications for our understanding of the mechanism of T cell proliferation as well as the regulation of PI 3-K activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15004153     DOI: 10.4049/jimmunol.172.6.3527

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  IL-17-producing NKT cells depend exclusively on IL-7 for homeostasis and survival.

Authors:  K E Webster; H-O Kim; K Kyparissoudis; T M Corpuz; G V Pinget; A P Uldrich; R Brink; G T Belz; J-H Cho; D I Godfrey; J Sprent
Journal:  Mucosal Immunol       Date:  2014-01-22       Impact factor: 7.313

2.  Interferon-α inhibits CD4 T cell responses to interleukin-7 and interleukin-2 and selectively interferes with Akt signaling.

Authors:  Thao P Nguyen; Doug A Bazdar; Joseph C Mudd; Michael M Lederman; Clifford V Harding; Gareth A Hardy; Scott F Sieg
Journal:  J Leukoc Biol       Date:  2015-03-17       Impact factor: 4.962

3.  LY294002 and rapamycin co-operate to inhibit T-cell proliferation.

Authors:  Elaine M Breslin; Paul C White; Angharad M Shore; Mathew Clement; Paul Brennan
Journal:  Br J Pharmacol       Date:  2005-03       Impact factor: 8.739

Review 4.  IL-7 signaling and CD127 receptor regulation in the control of T cell homeostasis.

Authors:  Florent Carrette; Charles D Surh
Journal:  Semin Immunol       Date:  2012-05-01       Impact factor: 11.130

Review 5.  Interlinking interleukin-7.

Authors:  Christina Kittipatarin; Annette R Khaled
Journal:  Cytokine       Date:  2007-09-04       Impact factor: 3.861

6.  Dual mechanism of impairment of interleukin-7 (IL-7) responses in human immunodeficiency virus infection: decreased IL-7 binding and abnormal activation of the JAK/STAT5 pathway.

Authors:  Olivier Juffroy; Florence Bugault; Olivier Lambotte; Ivan Landires; Jean-Paul Viard; Loïc Niel; Arnaud Fontanet; Jean-François Delfraissy; Jacques Thèze; Lisa A Chakrabarti
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

7.  STAT5 is essential for IL-7-mediated viability, growth, and proliferation of T-cell acute lymphoblastic leukemia cells.

Authors:  Daniel Ribeiro; Alice Melão; Ruben van Boxtel; Cristina I Santos; Ana Silva; Milene C Silva; Bruno A Cardoso; Paul J Coffer; João T Barata
Journal:  Blood Adv       Date:  2018-09-11

Review 8.  Orchestrating Lymphocyte Polarity in Cognate Immune Cell-Cell Interactions.

Authors:  Eugenio Bustos-Morán; Noelia Blas-Rus; Noa Beatriz Martín-Cófreces; Francisco Sánchez-Madrid
Journal:  Int Rev Cell Mol Biol       Date:  2016-07-30       Impact factor: 6.813

9.  Impaired CD8 T cell memory and CD4 T cell primary responses in IL-7R alpha mutant mice.

Authors:  Lisa C Osborne; Salim Dhanji; Jonathan W Snow; John J Priatel; Melissa C Ma; M Jill Miners; Hung-Sia Teh; Mark A Goldsmith; Ninan Abraham
Journal:  J Exp Med       Date:  2007-02-26       Impact factor: 14.307

10.  IL-12 and type I interferon prolong the division of activated CD8 T cells by maintaining high-affinity IL-2 signaling in vivo.

Authors:  Gabriel R Starbeck-Miller; Hai-Hui Xue; John T Harty
Journal:  J Exp Med       Date:  2013-12-23       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.